Vascular Stents Market Set for Steady Expansion by 2032, Driven by Innovation and Growing Surgical Volumes, DelveInsight | Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, Mic

The global vascular stents market was valued at USD 11,232.93 million in 2024 and is projected to grow at a CAGR of 6.35% from 2025 to 2032, reaching USD 18,277.68 million by 2032. This growth is largely driven by the increasing incidence of cardiovascular diseases and related risk factors such as obesity, hypertension, and diabetes, which are creating a greater demand for effective vascular treatments. Heightened awareness of heart health and the expansion of screening initiatives have led to earlier diagnosis and intervention, boosting the use of stenting procedures. Additionally, the global rise in angioplasty procedures has significantly contributed to the demand for vascular stents, which are essential for restoring proper blood circulation. Ongoing innovations and product advancements by leading market players are further improving clinical outcomes and broadening the application of stents, thereby fueling market expansion over the forecast period.

DelveInsight's Vascular Stents Market Insights report provides the current and forecast market analysis, individual leading Vascular Stents companies' market shares, challenges, Vascular Stents market drivers, barriers, and trends, and key Vascular Stents companies in the market.

Request for a detailed sample report: https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key Takeaways from the Vascular Stents Market Report
The Vascular Stents market is projected to grow at a moderate CAGR from 2025 to 2032.
As per DelveInsight estimates, North America is anticipated to dominate the global Vascular Stents market during the forecast period.
Notable Vascular Stents companies such as Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, SCITECH, and several others are currently operating in the Vascular Stents market.
In June 2024, Royal Philips, a prominent health technology company, announced the successful first implantation of its Duo Venous Stent System-an implantable device designed to treat symptomatic venous outflow obstruction in individuals with chronic venous insufficiency (CVI). This milestone followed the device's premarket approval (PMA) by the U.S. FDA.
In January 2024, W. L. Gore & Associates, Inc. (Gore) received FDA approval for its lower-profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft), enhancing treatment options for vascular conditions requiring stent graft intervention.
Also in January 2024, Reflow Medical, Inc.-a company specializing in cardiovascular medical devices-announced it had been granted CE Mark certification in the European Union for its Bare Temporary Spur Stent System. This device is intended for use in treating de novo or restenotic lesions in the infrapopliteal arteries, in conjunction with a commercially available drug-coated balloon (DCB), to improve drug uptake and clinical outcomes.

To read more about the latest highlights related to the Vascular Stents market, get a snapshot of the key highlights entailed in the Global Vascular Stents Market Report https://www.delveinsight.com/sample-request/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Vascular Stents Overview

Vascular stents are small, mesh-like medical devices used to open and support blood vessels that have been narrowed or blocked, often due to conditions like atherosclerosis. These stents are inserted into arteries or veins through minimally invasive procedures, typically during angioplasty, to restore and maintain adequate blood flow.


Vascular Stents Market Insights

North America is projected to lead the global vascular stents market in 2024, holding the largest market share among all regions. This dominance is largely driven by the region's high burden of cardiovascular diseases, robust healthcare infrastructure, and the strong presence of major medical device manufacturers. Additionally, factors such as elevated healthcare expenditure, supportive reimbursement frameworks, and rapid integration of advanced technologies further reinforce North America's position at the forefront of the vascular stents market.

According to 2024 data from the Centers for Disease Control and Prevention (CDC), about 4.9% of U.S. adults were diagnosed with coronary heart disease in 2022. By 2023, approximately 12.1 million people in the country were estimated to be living with atrial fibrillation. Moreover, over 795,000 individuals suffer a stroke annually in the U.S., with nearly 610,000 being first-time cases and around 185,000-roughly one in four-occurring in patients with a previous stroke history. The high prevalence of risk factors like obesity, diabetes, hypertension, and sedentary lifestyles has led to a growing incidence of coronary artery disease and stroke. As a result, the demand for vascular interventions such as coronary angioplasty has surged, where vascular stents play a vital role in restoring and maintaining adequate blood flow, further propelling market growth in the region.


To know more about why North America is leading the market growth in the Vascular Stents market, get a snapshot of the Vascular Stents Market Outlook https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Vascular Stents Market Dynamics

As per the British Heart Foundation (2025), an estimated 640 million people worldwide are currently living with heart and circulatory conditions. In addition, their 2024 report highlighted that coronary (ischemic) heart disease-the most prevalent form globally-affects approximately 200 million individuals, including around 110 million men and 80 million women.

This widespread prevalence of coronary artery disease is a key factor fueling the expansion of the vascular stents market. The condition, caused by plaque-induced narrowing or obstruction of coronary arteries, impedes blood flow to the heart, potentially resulting in angina, myocardial infarction, and other life-threatening issues. Vascular stents, especially drug-eluting types, are a cornerstone in treating ischemic heart disease by reopening and keeping arteries open following angioplasty, thereby driving significant demand within the market.

Moreover, according to 2024 data from the European Union, transluminal coronary angioplasty procedures were most frequently performed in Croatia (500.1 per 100,000 people), followed by Germany (379.3) and Bulgaria (378.4) in 2022. Across most EU nations, these procedures occurred at rates between 156 and 342 per 100,000 people. As angioplasty continues to be a widely used and minimally invasive approach for addressing arterial blockages, the accompanying use of stents-particularly advanced types like drug-eluting and bioresorbable stents-is critical to maintain vessel openness and reduce the risk of restenosis. With cardiovascular disease on the rise globally, this trend is expected to further escalate the demand for vascular stents.


Vascular Stents Market Drivers:
Rising cases of cardiovascular disorders and associated risk factors
Increasing awareness and screening programs
Rising number of angioplasty procedures globally
Increase in product development activities

Get a sneak peek at the Vascular Stents market dynamics @ https://www.delveinsight.com/sample-request/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Scope of the Vascular Stents Market Report:
Coverage: Global
Study Period: 2022 to 2032
Key Vascular Stents Companies: Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, SCITECH, and others.

Which MedTech key players in the Vascular Stents market are set to emerge as the trendsetter, explore @ Vascular Stents Companies https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Table of Contents

1. Vascular Stents Market Report Introduction
2. Vascular Stents Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Vascular Stents Market Key Factors Analysis
6. Vascular Stents Market Porter's Five Forces Analysis
7. Vascular Stents Market Layout
8. Vascular Stents Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Contact Info:

Kritika Rehani
Assistant Manager, Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.